New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Subscribe To Our Newsletter & Stay Updated
